Filing Details

Accession Number:
0001179110-13-012478
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-08-01 17:33:24
Reporting Period:
2013-07-30
Filing Date:
2013-08-01
Accepted Time:
2013-08-01 17:33:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1080014 Theravance Inc THRX Pharmaceutical Preparations (2834) 943265960
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1421050 Mathai Mammen Theravance, Inc.
901 Gateway Blvd.
South San Francisco CA 94080
Svp, Research & Early Clin Dev No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-07-30 7,000 $36.51 211,705 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. DISPOSITIONS MADE PURSUANT TO A PLAN INTENDED TO COMPLY WITH RULE 10b5-1(c).
  2. This transaction was executed in multiple trades at prices ranging from $36.16 to $37.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.